Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Advocating for People Managing Hermansky-Pudlak Syndrome

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:11724553
archived

In the third episode of our series highlighting rare diseases, Conference Forum reporter Danny McCarthy sits down with Fernando Albertorio, PhD, to discuss Hermansky-Pudlak Syndrome. 

Dr Albertorio is co-founder of Sunu, Inc, which creates wearable, IoT and mobile technology that empowers independence for people who a blind and visually impaired. Dr Albertorio is also an advocate for increasing awareness and treatments for managing Hermansky-Pudlak Syndrome (HPS). 

HPS is an extremely rare autosomal recessive disorder, characterized by albinism, visual impairment, and a platelet dysfunction that results in prolonged bleeding. There are currently 10 known types of HPS. 

In the episode, Dr Albertorio mentions several websites for more information: HPSNetwork.orgGlobalGenes.org and Sunu.com.

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled